Emilia Javorsky
speaker
1,653 appearances
2 recordings
1 series
first heard Mar 2026
last heard 20 Mar
Emilia Javorsky’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Mar 2026 with 2.
Appearances
268 off-patent drugs and 1,574 natural compounds have shown safety and potential anti-cancer effects.
Yet regulatory and market constraints prevent the testing needed to get these drugs to patients.
Current systemic constraints are already curtailing the potential of AI drug discovery capabilities and that of biology's progress more generally.
The intelligence exists, the science works, the medical need is dire, and yet the drugs don't reach patients.
If we can't solve this problem for current AI-discovered antibiotics or promising cancer drugs, what reason do we have to believe more compute is the solution?
Chapter 3.
Misguiding Myths and Errors
Cancer is the most complex of all diseases, inherent barriers to a universal cure.
When scientists underestimate complexity, they fall prey to the perils of unintended consequences, wrote Siddhartha Mukherjee in his Pulitzer Prize-winning history of cancer, the emperor of all maladies.
Cancer cure sits atop the list of superintelligence panaceas.
Yet, it may be the complex disease least likely to yield to any universal curative breakthrough, superintelligent or otherwise.
First, most of us already have potential cancers in our bodies.
Our bodies continuously produce cells with mutations that could become cancerous.
Yet our innate mechanisms of cell removal and immune surveillance eliminate these threats.
Cancer is not a foreign invader, but a breakdown in our own regulatory systems.
What we call cancer is not a single disease, but thousands of different diseases, each a product of distinct molecular drivers, cell types of origin,
evolutionary pressures, and micro-environments.
As Mukherjee eloquently put it, cancer's life is a recapitulation of the body's life, its existence a pathological mirror of our own.
In fact, even in a single tumor, there can be significant biological heterogeneity, meaning cells within the tumor have different pathways gone awry.
Early research into long-lived cancer-resilient mammals such as elephants, naked mole rats, and the 200-year-old bowhead whales sparked hope of finding a singular mechanism for cancer resistance.
Showing 861–880 of 1,653 · page 44 of 83
← Previous
Next →